Jane Warwick PhD

Jane Warwick is a Professor in Clinical Trials Statistics, at Warwick Clinical Trials Unit (WCTU), Warwick Medical School, University of Warwick, where she works to further develop Warwick CTU's portfolio of pragmatic clinical trials and related statistical research studies. She has over 25 years of experience in medical statistics, epidemiology and clinical trials. She obtained a BSc in Statistics (2.1) from the University of Birmingham (1987) and a PhD (thesis entitled "Selecting tuning parameters in minimum distance estimators", funded by an Open University Studentship, supervisor Professor M.C. Jones) from the Department of Mathematics and Statistics at the Open University (2002). Her first post in medical statistics was at the Cancer Research Campaign Clinical Trials Unit at the University of Birmingham where she specialised in gynaecological oncology and developed a particular interest in ovarian cancer.

After completing her PhD she joined the Cancer Research UK Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London where for ten years she worked with Professor Stephen Duffy on the evaluation of breast screening programmes and breast cancer aetiology and with Professor Jack Cuzick on breast cancer prevention and models to predict breast cancer risk. In 2011, to broaden her experience and develop her leadership skills, she moved to the Imperial Clinical Trials Unit, Imperial College London, where for 3 years she led the statistics team and gained experience in Phase II and III trials in a variety of clinical areas, including cancer, HIV, mental health, vascular surgery and critical care, and of Bayesian methods for adaptive trial designs. She joined Warwick CTU in 2014. She maintains her interest in cancer research through membership of external oversight committees (as an independent statistician) and has for many years been a reviewer for the NIHR EME and HTA programmes and for Cancer Research UK's Science Committee. In 2014 she was awarded the Translational Cancer Research Prize for her contribution to the IBIS team (led by Prof Jack Cuzick QMUL), specifically the design and analysis of the mammographic density sub-studies and the development of the methodology for incorporating mammographic density into the IBIS breast cancer risk evaluation model.